Robert G. Voigt, MD

Scientific Advisory Board, Member
Robert G. Voigt, MD

Robert G. Voigt, MD

Texas Children's Hospital and Baylor College of Medicine

Scientific Profile

Areas of Specialty: Dr. Voigt is board-certified in both Neurodevelopmental Disabilities and Developmental-Behavioral Pediatrics, and he specializes in the full spectrum of developmental disorders, from autism, intellectual disabilities, and cerebral palsy to ADHD, learning disabilities, and developmental coordination disorders.

Clinical Care and Research Activities: After serving in various leadership positions at Mayo Clinic in Rochester, Minnesota (including chair and fellowship program director of the division of developmental-behavioral pediatrics and pediatric residency program director), Dr. Voigt recently joined Baylor College of Medicine/Texas Children’s Hospital as Chief of Service and Director of the Meyer Center for Developmental Pediatrics, where he directs medical diagnostic services for children with, suspected of, and at risk for the full spectrum of developmental-behavioral disabilities.

From a research standpoint, Dr. Voigt has been involved in studies investigating the dietary interventions (omega-3 fatty acids) on neurodevelopment, the evaluation of developmental assessment instruments, and the epidemiology of neurodevelopmental disabilities, including autism, ADHD, and intellectual and learning disabilities. He has recently been involved as co-investigator on epidemiologic studies investigating the relationship between early exposure to anesthesia and the development of specific learning disabilities.

Recent Achievements

  • Editor in Chief, American Academy of Pediatrics textbook, Developmental and Behavioral Pediatrics (2011)
  • Editorial Board, Pediatrics (2011)
  • Executive Committee, AAP Section on Developmental-Behavioral Pediatrics (2002-2008)
  • Teacher of the Year Hall of Fame – Mayo Fellows Association (2008)
  • Teacher of the Year, Mayo Clinic Department of Pediatric and Adolescent Medicine (2005-2006. 2007-2008)
  • Nelson Butters Award for Research Contributions to Clinical Neuropsychology, National Academy of Neuropsychology (2002)


Scientific Advisory Board, Member

Baylor College of Medicine

Professor and Head, Section of Developmental Pediatrics

Texas Children’s Hospital

Chief of Developmental Pediatrics Service and Director, Meyer Center for Developmental Pediatrics


New York University School of Medicine, MD (1987)
Johns Hopkins University, BA (1983)


Fellowship, Developmental Pediatrics, Baylor College of Medicine (1993-1994)
Fellowship, Developmental Pediatrics, Medical University of South Carolina (1990-1991)
Internship/Residency, Pediatrics, Baylor College of Medicine (1987-1990)

Professional Affiliations

  • Association of Pediatric Program Directors
  • Academic Pediatric Association
  • American Academy for Cerebral Palsy and Developmental Medicine
  • American Academy of Pediatrics
  • American Board of Pediatrics, Sub-board on Developmental-Behavioral Pediatrics
  • Child Neurology Society
  • Society for Developmental and Behavioral Pediatrics
  • Society for Pediatric Research

Recent Research Funding

  • Population-Based Study of the Genomics and Long-Term Outcomes of AD/HD
    National Institute of Mental Health (2006-2011)
  • Anesthesia During Infancy
    Food and Drug Administration (2008-2010)
  • A Randomized, Double-blind, Placebo-Controlled Trial of Docosahexaenoic Acid (DHA) Supplementation in Children with Autism
    Mayo Foundation (2005-2007)
    Principal Investigator
  • Standardization of the Capute Scales (Cognitive Adaptive Test/Clinical Linguistic and Auditory Milestone Scale [CAT/CLAMS])
    Kennedy Fellows Association (2000-2001)
  • Effect of dietary docosahexaenoic acid (DHA) supplementation on children with ADHD
    Martek Biosciences Corporation (1997-1999)
    Principal Investigator

Selected Publications

Jensen CL, Voigt RG, Llorente A, Peters S, Prager T, Zou Y, Fraley JK, Heird WC.Effect of maternal docosahexaenoic acid (DHA) supplementation on neuropsychological and visual status of former breast-fed term infants at five years of age. J Pediatr 2010;157(6):875-6.

Ibrahim SH, Voigt RG, Katusic SK, Weaver AL, Barbaresi WJ. Incidence of gastrointestinal symptoms in children with autism: a population-based study. Pediatrics 2009;124(2):680-6.

Voigt RG, Johnson SK, Mellon MW, Hashikawa AH, Campeau LJ, Williams AR, Yawn BP, Juhn YJ. Relationship between parenting stress and concerns identified by developmental screening and their effects on parental medical care-seeking behavior. Clin Pediatr (Phila) 2009;48(4):362-8.

Voigt RG, Llorente AM, Jensen CL, Fraley JK, Barbaresi WJ, Heird WC.Comparison of the validity of direct pediatric developmental evaluation versus developmental screening by parent report. Clin Pediatr (Phila) 2007;46(6):523-9.

Voigt RG, Barbaresi WJ, Colligan RC, Weaver AL, Katusic SK. Developmental dissociation, deviance, and delay: Occurrence of attention-deficit-hyperactivity disorder in individuals with and without borderline-to-mild intellectual disability. Dev Med Child Neurol 2006;48(10):831-5.

Barbaresi WJ, Katusic SK, Voigt RG. Autism: a review of the state of the science for pediatric primary health care clinicians. Arch Pediatr Adolesc Med 2006;160(11):1167-75.

Jensen CL, Voigt RG, Prager TC, Zou YL, Fraley JK, Rozelle J, Turcich M, Llorente AM, Anderson RE, Heird WC. Effects of maternal docosahexaenoic acid intake on visual function and neurodevelopment of breast-fed term infants. Am Journal Clin Nutr 2005;82:1579-1586.

Voigt RG, Brown FR, Fraley JK, Llorente AM, Rozelle J, Turcich M, Jensen CL, Heird WC. Concurrent and predictive validity of the cognitive adaptive Test/Clinical Linguistic and Auditory Milestone Scale (CAT/CLAMS) and the Mental Developmental Index of the Bayley Scales of Infant Development. Clin Pediatr (Phila) 2003;42(5):427-32.

Voigt RG, Jensen CL, Fraley JK, Rozelle JC, Brown FR, Heird WC. Relationship between omega 3 long-chain polyunsaturated fatty acid status during early infancy and neurodevelopmental status at 1 year of age. J Hum Nutr Diet 2002;15(2):111-20.

Voigt RG, Llorente AM, Jensen CL, Fraley JK, Berretta MC, Heird WC. A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder. J Pediatr 2001;139(2):189-96.

Voigt RG, Childers DO, Dickerson CL, Juhn YJ, Reynolds AM, Rodriguez DL, Brown FR. Early pediatric neurodevelopmental profile of children with autistic spectrum disorders. Clin Pediatr (Phila) 2000 Nov;39(11):663-8.